US Broker Ratings

Celcuity Inc. (CELC) Stock Analysis: Biotechnology Innovator with a 50.60% Upside Potential

Celcuity Inc. (CELC), a Minneapolis-based clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to treating solid tumors. Founded in 2011, Celcuity has carved a..

RxSight, Inc. (RXST) Investor Outlook: Navigating the Market with a 9.60% Potential Upside

RxSight, Inc. (NASDAQ: RXST) offers a unique proposition within the healthcare sector, specifically in the medical devices industry. Known for its innovative approach to cataract surgery, RxSight has carved a..

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Analysis: Exploring a Potential 146.27% Upside in the Biotechnology Sector

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is generating significant buzz in the biotechnology sector, thanks to a promising pipeline of treatments aimed at serious retinal diseases. With an impressive average target..

Cross Country Healthcare, Inc. (CCRN)

⚠️ No article content returned.

..

Valneva SE (VALN) Stock Analysis: A Biotech with a 20% Upside Potential

Valneva SE (NASDAQ: VALN), a French biotechnology company, is capturing the attention of individual investors with its promising pipeline of vaccines targeting infectious diseases. Specializing in prophylactic vaccines, Valneva is..

Semler Scientific, Inc. (SMLR) Investor Outlook: A Healthcare Innovator with 166% Potential Upside

Semler Scientific, Inc. (NASDAQ: SMLR) is making waves in the healthcare sector, driven by its innovative medical devices aimed at enhancing clinical efficiency. Headquartered in Santa Clara, California, this company..

MeiraGTx Holdings plc (MGTX): Explosive Growth Potential with 212% Upside

MeiraGTx Holdings plc (NASDAQ: MGTX) is capturing the attention of investors with its compelling storyline in the biotechnology sector. With an impressive market cap of $704.72 million, this clinical-stage genetics..

AxoGen, Inc. (AXGN) Stock Report: Analyzing a 50% Upside Potential in the Medical Devices Sector

Investors looking for promising opportunities in the healthcare sector may find AxoGen, Inc. (NASDAQ: AXGN) worthy of consideration. Specializing in the niche market of peripheral nerve regeneration and repair, AxoGen..

Opthea Limited (OPT) Stock Analysis: Navigating the -70.67% Potential Downside

Opthea Limited (ASX: OPT) stands on the cusp of significant developments in the biotechnology sector with its promising clinical-stage biopharmaceutical pipeline. Based in Melbourne, Australia, Opthea is a key player..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a 109.60% Potential Upside in the Biotech Sector

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) presents a compelling case for investors keen on venturing into the biotechnology sector, an industry known for its high risk and high reward dynamics. With..

Verastem, Inc. (VSTM) Stock Analysis: A Biotech Powerhouse with 67.75% Potential Upside

Verastem, Inc. (NASDAQ: VSTM), a biopharmaceutical company specializing in oncology treatments, is capturing the interest of investors with its promising drug candidates and significant upside potential. As a development-stage biotech..

Arcus Biosciences (RCUS) Stock Analysis: Strong Buy Ratings and Nearly 100% Upside Potential

Arcus Biosciences, Inc. (RCUS) is capturing investor attention with its potential upside of 97.29%, driven by a pipeline of promising cancer therapies and robust buy ratings. As a biotechnology company..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Evaluating a 31.55% Upside in Biotech

Maze Therapeutics, Inc. (NASDAQ: MAZE) has been gaining considerable attention within the biotechnology sector, especially with its promising portfolio of precision medicines targeting renal, cardiovascular, and metabolic diseases. With a..

Bicycle Therapeutics plc (BCYC): Unpacking the 169% Potential Upside for Biotechnology Investors

Bicycle Therapeutics plc (NASDAQ: BCYC) is garnering significant attention in the healthcare sector with its promising biotechnology innovations. Headquartered in Cambridge, UK, Bicycle Therapeutics is carving a niche in the..

COMPASS Pathways Plc (CMPS) Stock Analysis: Exploring a 131% Potential Upside in Mental Health Innovation

COMPASS Pathways Plc (NASDAQ: CMPS), a key player in the burgeoning field of mental health treatment, is currently drawing investor attention with a remarkable potential upside of 131.37%. Specializing in..

Theravance Biopharma, Inc. (TBPH) Investor Outlook: Eyeing a 37.84% Upside Potential

Theravance Biopharma, Inc. (NASDAQ: TBPH) stands at the intersection of innovation and investor interest within the biotechnology sector. As a company focused on the development and commercialization of treatments for..

Oculis Holding AG (OCS) Stock Analysis: A Biotech Gem with 104.90% Upside Potential

Oculis Holding AG (OCS) presents a compelling opportunity for investors eyeing the biopharmaceutical sector, particularly in the realm of ophthalmic disease treatment. Headquartered in Zug, Switzerland, Oculis is a clinical-stage..

Delcath Systems, Inc. (DCTH) Stock Analysis: A Healthcare Innovator with 123.65% Potential Upside

Delcath Systems, Inc. (NASDAQ: DCTH) is making waves in the healthcare industry with its pioneering approach to interventional oncology, particularly in the treatment of primary and metastatic liver cancers. As..

AbCellera Biologics Inc. (ABCL) Stock Analysis: A Glimpse into the 57.92% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a pioneering force in the biotechnology sector, is capturing the attention of investors with its impressive growth metrics and strategic collaborations. With a market capitalization..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a Potential 97% Upside Amidst Telehealth Boom

LifeMD, Inc. (LFMD), a burgeoning player in the healthcare sector, is making waves in the health information services industry with its innovative approach to telehealth. Operating from its New York..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds